INTRODUCTION
Health care is one of the most important human activities and one of the most dynamic in terms of growth in expenses for its delivery. Numerous achievements in medicine, pharmaceuticals and medical technologies improve health status of people in most countries, but they also increase the cost. Therefore, the focus of health policy is to establish efficacy but also the effectiveness of health care. Health care costs are a burden that particular disease or group of diseases put on society [1] .
Realistic presentation of financial data in health care, in particular those relating to the monitoring costs for the treatment of patients with certain diseases are absolutely necessary. In the recent years, there was growing interest for calculating the costs of treating patients [2, 3, 4] , that have certain diseases [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , injuries [17] disorders [18] and conditions [19] [20] [21] [22] [23] [24] .
In 2000, Organization for Economic Development of countries (OECD) established the System of Health Accounts (SHA) that formulated indicative methodological guidance for calculating the cost of treating patients through the Table 6 . Until the initiation of new Methodological guidelines SHA 2011, the Table 6 in SHA was used [25] , as part of the National Health Accounts (NHA). That Table provides the current cost of health care according to the main groups of disorders by the International Classification of Diseases (ICD).
In the system of health accounts an individual health care costs are defined as those costs in the health system that do not involve shared health care like public health services, collective prevention, health insurance, health administration and costs for performing functions related to the health care.
The aim of this study was to perform a comparative analysis of the costs of individual health care in the Republic of Serbia by main groups of diseases (ICD) for the period 2010-2015.
MATERIALS AND METHODS
A comparative retrospective analysis of statistical data from the database of the Institute of Public Health of Serbia (IPHS) and financial data of the National Health Insurance Fund (NHIF) for the period 2010-2015 was performed.
Information about provided services for hospital, outpatient and home treatment, as well as day care, extra services, health care, drug consumption and consumer goods to health care, were analyzed and cross-compared with financial data from the Republic Health Insurance Fund after examination procedure of SHA (version 11).
The cost of individual health care in the Republic of Serbia, according to the main categories of the ICD was grouped into the following scheme and methodology of SHA 11:
• H.C. Retrospective and comparative research methods were applied in the analysis. Data obtained from the National Fund of Statistics (NFS) and the National Bank of Serbia (NBS) were used as well.
The following Tables present groups of diseases codes according to the International Classification of Diseases (Table 1) , as well as Table 6 that was used to calculate the cost of individual health care (Table 2) .
RESULTS
The results determined the cost of individual health care by main categories of the ICD The total sum (in RSD, Euros and US Dollars) that was spent for health care of population in Serbia during observed years, according to the ICD is shown in the Table 3 .
Total cost for individual health care by major ICD classification in 2010 was 151,331,867,999 RSD. In regards to the groups of diseases the highest individual cost was allocated for the circulatory system diseases (19.58%), neoplasms (10.0%), diseases of the digestive system (9.75%), nervous system diseases (8.33%), infectious and parasitic diseases (8.99%), while the least was for congenital anomalies (0.27%) (Figure 1 ). In 2010, the total individual cost for health care by main categories ICD per capita was € 195.00, and in relation to the gross domestic product (GDP) in 2010 it was 5.20%.
151,614,999,373 RSD in 2011 was the total individual cost for health care by major ICD categories. In relation to the groups of diseases the highest individual cost was allocated for the circulatory system diseases (19.14%), diseases of the digestive system (9.71%), infectious and parasitic diseases (8.88%) and neoplasms (8.90%), while the least was for congenital anomalies (0.30%) ( Figure  2 ). The total cost for individual health care by main categories of ICD in 2011 per capita was € 205.00, and it was 4.77% of the GDP for that year.
Total cost for individual health care by major ICD categories in 2012 was 166,575,285,407 RSD. The highest indi- vidual cost was observed by the following disease groups: circulatory system diseases (20.69%), diseases of the digestive system (10.38%), neoplasms (10.07%), nervous system (9.00%), and infectious parasitic diseases (8.69%), while the least was for congenital anomalies (0.23%) (Figure 3) . In 2012, the total individual cost for health care by major ICD categories per capita was € 205.00. That represented 4.97% of the GDP for the year 2012. In 2013, the total individual cost for health care by major ICD categories was 176,734,078,012 RSD. By the ICD classification, the greatest individual cost was allocated for the circulatory system diseases (20.44%), neoplasms (10.84%), diseases of the digestive system (10.62%), nervous system (8.74%), infectious parasitic diseases (8.51%), and the least for congenital anomalies (0.21%) (Figure 4 ). Individual cost for health care by main categories of ICD in 2013 per capita was € 219.00, being 4.88% of the GDP for 2013.
The total cost for individual health care by major ICD categories in 2014 was 183,189,009,508 RSD. The individual cost was allocated mostly for the circulatory system diseases (18.62%), nervous system (11,79), diseases of the digestive system (10.74%), neoplasms (10.62%), infectious and parasitic diseases (8.79%), and the least for congenital anomalies (0.34%) and perinatal conditions (1.15%) ( Figure 5 ). In 2014, the total individual cost for health care by main categories ICD per capita was € 217.00. That (Table 5) .
DISCUSSION
It has been shown that studies about the cost of health care of patients [2] [3] [4] usually focus on the particular disease [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , or individual injuries [17] , disorders [18] or conditions only [19] [20] [21] [22] [23] [24] . Current costs of health care for major groups of diseases ICD are presented in Table 6 of SHA, as part of the National Health account (NHA) [25] . Many users believe that the analysis of table 6 SHA, entitled "Costs of health care by the main groups of the International Classification of Diseases" is the most important and useful for health politics decision-making. Although there is still no widely accepted clear methodological instructions for establishing table 6 (except the framework, that was used in the present study), international comparisons based on this table have started to perform now [27] . International comparability is actually major advantage of the Table 6 . Its disadvantage, however, is that the cost estimates in different countries vary in scope and methodology of the assessment, so that they are based on a large set of assumptions or very small samples.
The total cost of health care for the residents of the Republic of Serbia by the ICD from 2010 to 2015 increased from about 151 billion to almost 194 billion RSD. Expenditure per capita expressed in euros has also increased during the period, from 195 euros in 2010 up to 223 euros in 2015. Expenditure per capita expressed in US dollars during this period recorded the same changes. By groups of diseases, the highest health care cost in the period 2010-2015 in the Republic of Serbia was used for the treatment of patients with cardiovascular diseases, and during this period increased thirty percent. Compared to the increase of funds for other disease groups, this was growth higher than average.
When this cost is compared with findings from Australia, Canada, France, Germany and the Netherlands [27] , it is evident that in these countries the largest assets within the healthcare were allocated for cardiovascular diseases, which is most likely the result of today's rapid and stressful lifestyle.
Unlike Serbia, where funds allocated for neoplasm are on the second place, followed by diseases of the digestive system, infectious and parasitic diseases, and diseases of the nervous system in other analyzed countries diseases of the nervous system are the second largest participation funding, followed by diseases of digestive system, musculoskeletal system and neoplasm. At the end of this period (2015) after cardiovascular diseases (19.8%) that had the highest consumer funds, the second place was for diseases of the digestive system (10.67%), followed by neoplasm (10.13%). Cardiovascular diseases (CVD) represents a major economic burden to the health care system in Serbia in terms of direct costs (e.g., hospitalization, rehabilitation, doctor visits, drugs) and indirect costs related to the mortality and morbidity (e.g., productivity loss due to premature death, and short-term or long-term disability). When the results of the cost of CVD in Serbia is compared with the same cost from Australia, Canada and some European countries, it is evident that in these countries, the situation tends to be very similar in terms of health care costs.
A review of studies published in Australia, revealed that cardiovascular diseases had the highest level of health care expenditure compared to any group of diseases in Australia, and that puts them in front of the funds allocated for oral health, mental disorders, and musculoskeletal diseases. According to their research, spending on CVD has remained relatively stable at around 12% of all expenditures for the period 2000-2009, while the cost of CVD in Serbia is still increasing [28] . In the observed period the total cost reached 19% of all health care costs in 2015.
When compared by years, the total health care cost by major ICD categories showed tendency of growth, increasing by almost thirty percent. Rising costs in the Republic of Serbia for the treatment of diseases over the years suggest insufficient investment in prevention, public health services, capital investment and other functions related to the health care.
The percentage share of health care costs by major ICD categories by the GDP for the period 2010-2015 dropped from 5.20% to 4.89% in 2015 showing that there is room for more funds to be allocated to the health care. There are no available data for other countries and other years so data are not comparable.
CONCLUSION
Individual costs of treating patients in the period 2010-2015 increased by thirty percent and the largest funds in Serbia was allocated to treat people with cardiovascular diseases. The cost of treating cardiovascular diseases is likely to continue to grow due to increased stress, bad habits, increased rates of obesity and aging society. To minimize steadily increasing individual costs for cardiovascular diseases, it is crucial to work on prevention and promotion of CVD and development of a comprehensive study that will provide detailed understanding of the cost of CVD and its main drivers. 
UVOD
Zdravstvena zaštita je jedna od najvažnijih ljudskih delatnosti i jedna od najdinamičnijih u pogledu rasta troškova za njeno obezbeđenje. Brojna dostignuća u medicini, farmaceutici, medicinskim tehnologijama, utiču na poboljšanje zdravstvenog stanja ljudi u većini zemalja, ali i na rast troškova, pa je briga za uspostavljanje efikasnosti i efektivnosti zdravstvene zaštite sve više u fokusu zdravstvene politike. Troškovi zdravstvene zaštite predstavljaju teret kojim određena bolest ili grupa oboljenja opterećuje društvenu zajednicu [1] .
Potreba za realnim prikazom finansijskih podataka u zdravstvenoj zaštiti, a posebno onih koji se odnose na praćenje troš-kova za lečenje bolesnika od određenih bolesti nameće se kao neophodnost. U skladu sa tim poslednjih godina raste interesovanje za izračunavanje troškova lečenja bolesnika [2, 3, 4] , a studije širom sveta obrađuju kako pojedine bolesti [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , tako i povrede [17] , poremećaje [18] i stanja [19] [20] [21] [22] [23] [24] .
Godine 2000. Organizacija za ekonomski razvoj država (Organisation for Economic Co-operation and Development -OECD) formirala je Sistem zdravstvenih računa (SZR), koji je formulisao okvirno metodološko uputstvo za izračunavanje cene lečenja bolesnika, kroz tabelu broj 6. Do pojave novog metodološkog uputstva SZR 2011. koristila se tabela broj 6 u SZR [25] , kao deo Nacionalnog zdravstvenog računa (NZR). U pomenutoj tabeli prikazani su tekući troškovi zdravstvene zaštite prema glavnim grupama oboljenja Međunarodne klasifikacije bolesti (MKB).
U Sistemu zdravstvenih računa su kao troškovi INDIVIDU-ALNE zdravstvene zaštite definisani svi oni troškovi u zdravstvenom sistemu koji ne uključuju kolektivnu zdravtsvenu zaštitu, koju čine usluge javnog zdravstva, kolektivna prevencija, zdravstveno osiguranje, zdravstvena administracija i troškovi za vršenje funkcija u vezi sa zdravstvenom zaštitom.
Cilj ovog rada je bio da se izvrši komparativna analiza troš-kova individualne zdravstvene zaštite u Republici Srbiji prema glavnim grupama oboljenja MKB za period 2010-2015. godine.
MATERIJAL I METODE RADA
Urađena je komparativna retrospektivna analiza statističkih podataka iz baze Instituta za javno zdravlje Srbije (IZJZS) i finansijskih podataka Republičkog fonda za zdravstveno osiguranje (RFZO) za period 2010-2015. godine.
Podaci o izvršenim uslugama bolničkog, ambulantnog i kuć-nog lečenja, kao i dnevne nege, pomoćnim uslugama zdravstvene zaštite, potrošnji lekova i potrošnih dobara u zdravstvu analizirani su i ukršteni su sa finansijskim podacima iz Republičkog fonda za zdravstveno osiguranje po metodološkom uputstvu SZR (verzija 11).
Troškovi individualne zdravstvene zaštite u Republici Srbiji prema glavnim kategorijama MKB rađeni su po sledećoj shemi i metodologiji SZR 11:
• H.C. 
